DY
Dyne Therapeutics
DYN·NASDAQWaltham MAFounded 2016200 employees
Small CapbiotechPublicRare DiseaseMusculoskeletal
Platform: FORCE DM1 DMD
Market Cap
$1.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (DYN)
Loading DYN stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| DYN-8432 | DYN-8432 | Phase 1/2 | 2 | USP1 | CholangiocarcinomaMDD | ||
| DYN-9663 | DYN-9663 | Approved | 1 | GPRC5D | SchizophreniaFabry |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)